- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/14 - Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Patent holdings for IPC class A61P 25/14
Total number of patents in this class: 1908
10-year publication summary
|
80
|
125
|
158
|
151
|
143
|
169
|
152
|
142
|
150
|
108
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2709 |
30 |
| Neurocrine Biosciences, Inc. | 470 |
30 |
| Taisho Pharmaceutical Co., Ltd. | 845 |
29 |
| Auspex Pharmaceuticals, LLC | 67 |
23 |
| Daiichi Sankyo Company, Limited | 1900 |
20 |
| Prilenia Neurotherapeutics Ltd. | 100 |
20 |
| Kyoto University | 2947 |
18 |
| The Regents of the University of California | 20960 |
16 |
| Sage Therapeutics, Inc. | 206 |
14 |
| Sumitomo Pharma Co., Ltd. | 561 |
14 |
| F. Hoffmann-La Roche AG | 7795 |
13 |
| PTC Therapeutics, Inc. | 464 |
13 |
| Sumitomo Dainippon Pharma Co., Ltd. | 210 |
13 |
| Praxis Precision Medicines, Inc. | 238 |
13 |
| Adeptio Pharmaceuticals Limited | 20 |
12 |
| Duke University | 3190 |
11 |
| Vanderbilt University | 2034 |
11 |
| Voyager Therapeutics, Inc. | 292 |
11 |
| Hoffmann-La Roche Inc. | 3864 |
10 |
| Ovid Therapeutics Inc | 180 |
10 |
| Other owners | 1577 |